COMP <GO>
AVAH vs UNH // EV/EBITDA & P/E VALUATION
Aveanna Healthcare Holdings Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: AVAH 5
— UNH 7
▲ EV/EBITDA & P/E VALUATION LEADER: AVAH
LAST: $13.26 (+1.53%) • MKT CAP: $2.89B
valuation
15.5x
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
valuation
16.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVAH VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AVAH | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 33.30% | 88.57% | -55.27 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 15.70% | 11.47% | +4.23 | AVAH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 15.5x | 16.4x | -0.95 | AVAH | /valuation <GO> |
| Free Cash Flow Yield | 4.35% | 6.48% | -2.13 | UNH | /fcf-yield <GO> |
| Operating Margin | 10.50% | 4.82% | +5.68 | AVAH | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 3.14% | -3.14 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 20.20% | 6.46% | +13.74 | AVAH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.86 | 3.12 | -1.26 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | AVAH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.0 | 59.2 | -3.16 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.89B | $368.83B | -$365.94B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AVAH REV | UNH REV | AVAH GROSS % | UNH GROSS % | AVAH FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.43B | $447.57B | 33.3% | 88.7% | $125.9M | $16.07B |
| FY 2024 | $2.02B | $400.28B | 31.4% | 88.3% | $32.6M | $20.70B |
| FY 2023 | $1.90B | $371.62B | — | 89.6% | $22.7M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVAH // BETA —
UNH // BETA 0.33